Recombinant Human Versican Isoform V3 His-tag Protein, CF Summary
Leu21-Tyr646, with a C-terminal 6-His tag
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
|Formulation||Lyophilized from a 0.2 μm filtered solution in PBS.|
|Reconstitution||Reconstitute at 500 μg/mL in PBS.|
|Shipping||The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.|
|Stability & Storage:||Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
When Recombinant Human Versican Isoform V3 (Catalog # 3054-VN) is coated at 0.25 μg/mL, 100 μL/well, Biotinylated Hyalurinan binds with an ED50 of 0.25-1.5 ng/mL.
2 μg/lane of Recombinant Human Versican Isoform V3 was resolved with SDS-PAGE underreducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Bluestaining, showing bands at 78-89 kDa and 67-80 kDa, respectively.
Versican (versatile proteoglycan; also known as PG-M, CSPG2, ERVR, GHAP, WGN, WGN1) is a 500-600 kDa, secreted member of the large aggregating chondroitin sulfate proteoglycan family, which includes aggrecan, neurocan, and brevican (1-3). The canonical sequence of human Versican (Isoform V0) is 3396 amino acids (aa) in length. It contains an N-terminal hyaluronan-binding region, two large, alternately spliced GAG attachment domains (GAG alpha and GAG beta), two EGF-like domains, a selectin-like region, and a complement regulatory protein-like domain (2). Human Versican has multiple alternative splice variants that include variations mainly in the GAG regions. This product is the Isoform V3 which includes one mutation at aa 348 (Pro to Arg) and lacks of the entire GAG domains (aa 349-3089) compared to Isoform V0. Versican is known to associate with hyaluronan (4), tenascin (5-7), fibronectin (8), fibulin (9), and CD44 (10) in the extracellular matrix that may contribute to the malignant properties of tumor cells (11). It has an anti-adhesive effect on cells, facilitating tumor migration and invasion (12). The multiple alternative splice variants of human Versican could affect cell-cell and cell-matrix adhesion (13-15), migration (16), proliferation, apoptosis (17), and mesenchymal-epithelial transition (18). The Versican gene is expressed in several different tissues, and it is over-expressed in several cancer types, including prostate (19), brain (20), ovary (21), breast (22) and melanoma (11).
- Shinomura, T. et al. (1993) J. Biol. Chem. 268:14461.
- Zimmermann, D. R. and E.Ruoslahti (1989) EMBO J. 8:2975.
- Margolis, R. U. and R. K. Margolis (1994) Methods Enzymol. 245:105.
- Lebaron, R. G. et al. (1992) J. Biol. Chem. 267:10003.
- Perides, G. et al. (1993) Anat. Embryol. (Berl.) 188:467.
- Aspberg, A. et al. (1995) Proc. Natl. Acad. Sci. U.S.A. 92:10590.
- Aspberg, A. et al. (1997) Proc. Natl. Acad. Sci. U.S.A. 94:10116.
- Braunewell, K. H. et al. (1995) Eur. J. Neurosci. 7:805.
- Olin, A. I. et al. (2001) J. Biol. Chem. 276:1253.
- Kawashima, H. et al. (2000) J. Biol. Chem. 275:35448.
- Touab, M. et al. (2002) Am. J. Pathol. 160:549.
- Yamagata, M. et al. (1989) J. Biol. Chem. 264:8012.
- Wu, Y. et al. (2002) J. Biol. Chem. 277:12294.
- Zheng, P. S. et al. (2004) J. Cell Sci. 117:5887.
- Lemire, J. M. et al. (2002) J. Cell Physiol. 190:38.
- Mjaatvedt, C.H. et al. (1998) Dev. Biol. 202:56.
- Sheng, W. et al. (2005) Mol. Biol. Cell. 16:1330.
- Sheng, W. et al. (2006) Mol. Biol. Cell. 17:2009.
- Ricciardelli, C. et al. (1998) Clin. Cancer Res. 4:963.
- Paulus, W. et al. (1996) J. Neuropathol. Exp. Neurol. 55:528.
- Voutilainen, K. et al. (2003) Int. J. Cancer 107:359.
- Nara, Y. et al. (1997) Histochem. J. 29:21.
No product specific FAQs exist for this product, however you mayView all Proteins and Enzyme FAQs
Reviews for Recombinant Human Versican Isoform V3 His-tag Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human Versican Isoform V3 His-tag Protein, CF and earn rewards!
Have you used Recombinant Human Versican Isoform V3 His-tag Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image